Breaking: Tyson Foods Q3 Misses Mark; Ginkgo Bioworks' Merck Deal Shakes Up
- August 07th, 2023
- 287 views
Tyson Foods, Inc. (NYSE: TSN) has released its third-quarter fiscal 2023 financial results, reporting adjusted earnings per share (EPS) of $0.15 and revenues totaling $13.14 billion. These figures fell short of market consensus estimates of $0.26 EPS on revenues of $13.59 billion.
$TSN was trading at $52.67 in pre-market, down $3.79 (-6.71%).
In other news, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) has unveiled a strategic partnership with Merck & Co., Inc. (NYSE: MRK).
The collaboration agreement, which marks the second between the companies and is aimed at improving biologic manufacturing, outlines the potential for Ginkgo to receive up to $490 million, encompassing upfront research fees, milestones, and commercial payments.
In pre-market, $DNA was trading at $2.18, reflecting an increase of $0.14 (+6.86%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024Key Metrics: CyberArk Software, Hudbay Minerals, and Sonos Earnings Due
November 11th, 2024Earnings: What to Expect from Occidental Petroleum, Rocket Lab, and CAE
November 10th, 2024Earnings Countdown: Home Depot, Sea Limited, and Natera in the Spotlight
November 10th, 2024Ahead of Earnings: DoorDash, MetLife, and Exelon in the Spotlight
October 27th, 2024
Member Login